CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
Cited by 52
Related Papers
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
|Signal Transduction and Targeted Therapy|2020|216
Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
|Signal Transduction and Targeted Therapy|2017|126
Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
|PLoS ONE|2013|93
Inhibition of <scp>XPO</scp>1 enhances cell death induced by <scp>ABT</scp>‐199 in acute myeloid leukaemia via Mcl‐1
|Journal of Cellular and Molecular Medicine|2018|63